These opportunities are not managed nor endorsed by RCPCH. Though we do our best to ensure they are relevant and high quality, we cannot take any responsibility for their content or accuracy. If you have questions or would like to submit a joint funding application with the College, contact us on email@example.com.
Smaller awards designed to allow for the exploration of original ideas in inherently novel priority asthma research areas and to stimulate innovation in asthma science.
Provides funding for innovative and relevant research on the ataxias that fit into an explicit therapeutic strategy. Will consider research projects, PhD studentships and research fellowships.
Funding for UK-registered medical practitioners for either research in progress or prospective paediatric research.
Provides funding for a variety of different subject areas, ranging from research into rheumatism and arthritis, to cardiovascular disease, cancer and neurological disorders.
Funds research into malignant and benign colorectal disease and /or research into Bowel Disease (with a preference for colorectal cancer).
Grants are offered for research projects that further the goals of ‘VISION 2020: The Right to Sight’. Research grants are available to clinicians, scientists or epidemiologists for 'pump-priming' to develop their research ideas and generate pilot data to facilitate a future application for a substantial grant or to provide funding for a non-clinical PhD or DrPH studentship.
Funding is available to support a PhD student performing research in one or more of the following priority areas: chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), children’s lung disease and bronchiectasis.
Funds UK or Republic of Ireland based research, which will benefit patients with skin disease and will benefit dermatological research in the future.
This scheme provides funding for biomarker assay development, validation and qualification where there is a clear line of sight to clinical implementation.
Aims to fund a UK-wide study to describe the occurrence of IBD (inflammatory bowel disease), stratified by age, socioeconomic status, ethnicity and geographical location.